$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

$foxo Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224032961 Filed on August 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue	$1.196M	$28.00K	$110.0K
YoY Change	11860.0%	133.33%	-73.81%
Cost Of Revenue		$31.00K	$62.00K
YoY Change		158.33%	-81.76%
Gross Profit		-$3.000K	$48.00K
YoY Change			-31.43%
Gross Profit Margin		-10.71%	43.64%
Selling, General & Admin	$1.733M	$1.474M	$4.298M
YoY Change	-63.26%	-63.18%	-62.95%
% of Gross Profit			8954.17%
Research & Development	$43.00K	$104.0K	-$24.00K
YoY Change	-84.81%	-68.77%	-102.7%
% of Gross Profit			-50.0%
Depreciation & Amortization	$17.00K	$52.00K	$28.00K
YoY Change	-77.33%	-79.2%	-97.89%
% of Gross Profit			58.33%
Operating Expenses	$2.201M	$1.617M	$3.732M
YoY Change	-36.15%	-78.77%	-83.47%
Operating Profit	-$1.005M	-$1.589M	-$3.684M
YoY Change	-71.34%	-79.11%	-83.63%
Interest Expense		-$542.0K	-$199.0K
YoY Change		-210.16%	-99.22%
% of Operating Profit
Other Income/Expense, Net	-$948.0K	-$575.0K	$24.00K
YoY Change	2212.2%	-591.45%	-140.0%
Pretax Income	-$1.953M	-$2.164M	-$3.859M
YoY Change	-46.64%	-80.83%	-91.97%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$1.946M	-$2.163M	-$4.771M
YoY Change	-46.83%	-80.85%	-90.07%
Net Earnings / Revenue	-162.71%	-7725.0%	-4337.27%
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.24	-$0.70
COMMON SHARES
Basic Shares Outstanding	13.63M shares	10.67M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$33.00K	$38.00K
YoY Change		-85.0%	-99.31%
Cash & Equivalents	$34.00K	$33.00K	$38.00K
Short-Term Investments
Other Short-Term Assets	$162.0K	$104.0K	$109.0K
YoY Change	52.83%	-0.95%	-4.39%
Inventory			$0.00
Prepaid Expenses	$502.0K	$76.00K	$86.00K
Receivables	$2.001M	$276.0K
Other Receivables		$0.00
Total Short-Term Assets	$2.909M	$489.0K	$233.0K
YoY Change	12.53%	-85.31%	-98.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$387.0K	$227.0K	$14.00K
YoY Change
Goodwill	$33.16M	$2.369M
YoY Change
Intangibles	$2.105M	$2.363M	$378.0K
YoY Change		395.39%	-81.5%
Long-Term Investments
YoY Change
Other Assets			$114.0K
YoY Change			-99.46%
Total Long-Term Assets	$39.76M	$6.417M	$492.0K
YoY Change	7182.42%	792.49%	-97.87%
TOTAL ASSETS
Total Short-Term Assets	$2.909M	$489.0K	$233.0K
Total Long-Term Assets	$39.76M	$6.417M	$492.0K
Total Assets	$42.67M	$6.906M	$725.0K
YoY Change	1262.86%	70.64%	-97.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.204M	$5.307M	$4.556M
YoY Change	70.35%	31.98%	31.45%
Accrued Expenses	$12.56M	$1.954M	$1.696M
YoY Change	721.79%	39.67%	62.3%
Deferred Revenue
YoY Change
Short-Term Debt		$7.982M	$0.00
YoY Change
Long-Term Debt Due			$4.203M
YoY Change			198.09%
Total Short-Term Liabilities	$34.35M	$21.31M	$14.34M
YoY Change	154.12%	109.75%	107.38%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$100.0K	$219.0K	$489.0K
YoY Change	-86.07%	-76.2%	-97.56%
Total Long-Term Liabilities	$100.0K	$219.0K	$489.0K
YoY Change	-86.07%	-76.2%	-97.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.35M	$21.31M	$14.34M
Total Long-Term Liabilities	$100.0K	$219.0K	$489.0K
Total Liabilities	$60.23M	$23.07M	$14.83M
YoY Change	323.11%	108.3%	-48.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$183.7M	-$181.7M	-$177.1M
YoY Change	6.64%	7.75%	20.26%
Common Stock	$1.000K	$1.000K	$1.000K
YoY Change	-83.33%	-80.0%	-66.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$17.51M	-$16.13M	-$14.10M
YoY Change
Total Liabilities & Shareholders Equity	$42.67M	$6.906M	$725.0K
YoY Change	1262.86%	70.64%	-97.95%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$1.946M	-$2.163M	-$4.771M
YoY Change	-46.83%	-80.85%	-90.07%
Depreciation, Depletion And Amortization	$17.00K	$52.00K	$28.00K
YoY Change	-77.33%	-79.2%	-97.89%
Cash From Operating Activities		-$1.165M	-$480.0K
YoY Change		-39.95%	-90.94%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$259.0K	$0.00
YoY Change
Cash From Investing Activities		-$259.0K	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		1.454M	476.0K
YoY Change			-4.8%
NET CHANGE
Cash From Operating Activities		-1.165M	-480.0K
Cash From Investing Activities		-259.0K	0.000
Cash From Financing Activities		1.454M	476.0K
Net Change In Cash		30.00K	-4.000K
YoY Change		-101.55%	-99.92%
FREE CASH FLOW
Cash From Operating Activities		-$1.165M	-$480.0K
Capital Expenditures		$0.00
Free Cash Flow		-$1.165M
YoY Change		-39.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2024Q2	us-gaap	Other Assets OtherAssets		usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2024Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q2	FOXO	Direct Costs Of Revenues DirectCostsOfRevenues		usd
	FOXO	Direct Costs Of Revenues DirectCostsOfRevenues		usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q2	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	FOXO	Loss From Note Amendment And Debenture Release LossFromNoteAmendmentAndDebentureRelease		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments		usd
	FOXO	Legal Settlement Paid In Common Stock LegalSettlementPaidInCommonStock		usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies		usd
	FOXO	Increase Decrease In Change In Rightofuse Lease Obligation Change In Rightofuse Lease Asset IncreaseDecreaseInChangeInRightofuseLeaseObligationChangeInRightofuseLeaseAsset		usd
	FOXO	Increase Decrease In Change In Rightofuse Lease Liability IncreaseDecreaseInChangeInRightofuseLeaseLiability		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense		usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense		usd
	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2024Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2024Q2	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease		usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease		usd
	FOXO	Debenture Release DebentureRelease		usd
	FOXO	Payment In Kind Note Amendment PaymentInKindNoteAmendment		usd
	FOXO	Deemed Dividends From Exchange Offer DeemedDividendsFromExchangeOffer		usd
	FOXO	Deemed Dividends From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendsFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
	FOXO	Warrants Issuable For Finders Fees WarrantsIssuableForFindersFees		usd
	FOXO	Stock Issued During Period Shares Shares Issuable For Acquisition StockIssuedDuringPeriodSharesSharesIssuableForAcquisition		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39783
	dei	Entity Registrant Name EntityRegistrantName	FOXO TECHNOLOGIES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1050265
	dei	Entity Address Address Line1 EntityAddressAddressLine1	729 N. Washington Ave.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55401
	dei	City Area Code CityAreaCode	(612)
	dei	Local Phone Number LocalPhoneNumber	562-9447
	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001
	dei	Trading Symbol TradingSymbol	FOXO
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13631554	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.0001
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	276000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	76000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	86000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	104000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	109000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	489000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	233000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	227000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1458000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2363000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	378000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2369000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	100000	usd
CY2024Q2	us-gaap	Assets Assets	6906000	usd
CY2023Q4	us-gaap	Assets Assets	725000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5307000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4556000	usd
CY2024Q2	FOXO	Related Parties Payables And Promissory Notes RelatedPartiesPayablesAndPromissoryNotes	3584000	usd
CY2023Q4	FOXO	Related Parties Payables And Promissory Notes RelatedPartiesPayablesAndPromissoryNotes	1591000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	7982000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4203000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1954000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1696000	usd
CY2024Q2	FOXO	Accrued Settlement AccruedSettlement	1974000	usd
CY2023Q4	FOXO	Accrued Settlement AccruedSettlement	2260000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110000	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	395000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	30000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	21306000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1348000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	219000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	23073000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	165564000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-181693000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-16128000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	-39000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16167000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6906000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28000	usd
CY2024Q2	FOXO	Direct Costs Of Revenues DirectCostsOfRevenues	31000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	104000	usd
CY2024Q2	FOXO	Management Contingent Share Plan Expense ManagementContingentSharePlanExpense	8000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2633000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2633000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1474000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1617000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1589000	usd
CY2023Q2	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease	-3521000	usd
	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease	-3521000	usd
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	542000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-33000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-575000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2164000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-2164000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2163000	usd
CY2024Q2	FOXO	Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants	310000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2473000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6708000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6708000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7639000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	901000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-30000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-30000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13759000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	773000	usd
CY2023Q2	FOXO	Debenture Release DebentureRelease	2181000	usd
CY2023Q2	FOXO	Payment In Kind Note Amendment PaymentInKindNoteAmendment	1339000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2466000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7030000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7030000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14100000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14100000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2160000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	103000	usd
CY2024Q1	FOXO	Shares Issued Under Kr Eight Agreement Value SharesIssuedUnderKREightAgreementValue	378000	usd
CY2024Q1	FOXO	Stock Issued During Period Value Share Issued Under Corporate Development And Advisory Agreement StockIssuedDuringPeriodValueShareIssuedUnderCorporateDevelopmentAndAdvisoryAgreement	153000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	16000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	17000	usd
CY2024Q1	FOXO	Deemed Dividends From Trigger Of Down Round Provisions DeemedDividendsFromTriggerOfDownRoundProvisions	656000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14937000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14937000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2473000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	68000	usd
CY2024Q2	FOXO	Stock Issued During Period Value Shares Issuable Under Terms Of Note Payable StockIssuedDuringPeriodValueSharesIssuableUnderTermsOfNotePayable	28000	usd
CY2024Q2	FOXO	Stock Issued During Period Value Shares Issued To Lgh Under Terms Of Note Payable StockIssuedDuringPeriodValueSharesIssuedToLghUnderTermsOfNotePayable	57000	usd
CY2024Q2	FOXO	Stock Issued During Period Value Shares Issued For Legal Settlement StockIssuedDuringPeriodValueSharesIssuedForLegalSettlement	286000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	43000	usd
CY2024Q2	FOXO	Stock Issued During Period Shares Shares Issuable For Myrtle Acquisition StockIssuedDuringPeriodSharesSharesIssuableForMyrtleAcquisition	235000	usd
CY2024Q2	FOXO	Stock Issued During Period Shares Shares Issuable To Institutional Investors Under Terms Of Senior Notes Payable StockIssuedDuringPeriodSharesSharesIssuableToInstitutionalInvestorsUnderTermsOfSeniorNotesPayable	255000	usd
CY2024Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	38000	usd
CY2024Q2	FOXO	Stock Issued During Period Shares Deemed Dividends From Trigger Of Down Round Provisions Of Assumed Warrant StockIssuedDuringPeriodSharesDeemedDividendsFromTriggerOfDownRoundProvisionsOfAssumedWarrant	310000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16167000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16167000	usd
	us-gaap	Profit Loss ProfitLoss	-3668000	usd
	us-gaap	Profit Loss ProfitLoss	-18932000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	522000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1176000	usd
	FOXO	Loss From Note Amendment And Debenture Release LossFromNoteAmendmentAndDebentureRelease	-3521000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	187000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1673000	usd
	FOXO	Amortization Of Consulting Fees Paid In Common Stock AmortizationOfConsultingFeesPaidInCommonStock	101000	usd
	FOXO	Amortization Of Consulting Fees Paid In Common Stock AmortizationOfConsultingFeesPaidInCommonStock	2221000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2633000	usd
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	100000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-208000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	504000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	275000	usd
	FOXO	Legal Settlement Paid In Common Stock LegalSettlementPaidInCommonStock	286000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	282000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	448000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-1000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	-11000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-61000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1435000	usd
	FOXO	Increase Decrease In Change In Rightofuse Lease Obligation Change In Rightofuse Lease Asset IncreaseDecreaseInChangeInRightofuseLeaseObligationChangeInRightofuseLeaseAsset	-1458000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-13000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-9000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1170000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	555000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1001000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-116000	usd
	FOXO	Increase Decrease In Change In Rightofuse Lease Liability IncreaseDecreaseInChangeInRightofuseLeaseLiability	-1458000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	551000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5300000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	259000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2122000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2381000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	265000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	48000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1608000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1825000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5300000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5515000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	215000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_809_eus-gaap--NatureOfOperations_zz7V1GvYQCmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: -45.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Note 1 <span id="xdx_82B_zL2yBoBbrtLg">DESCRIPTION OF BUSINESS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOXO Technologies Inc. (“FOXO” or the “Company”), formerly known as Delwinds Insurance Acquisition Corp. (“Delwinds”), a Delaware corporation, was originally formed in April 2020 as a publicly traded special purpose company for the purpose of effecting a merger, capital stock exchange, asset acquisition, reorganization, or similar business combination involving one or more businesses. FOXO is commercializing epigenetic biomarker technology to support groundbreaking scientific research and disruptive next-generation business initiatives. The Company applies automated machine learning and artificial intelligence (“AI”) technologies to discover epigenetic biomarkers of human health, wellness and aging and, with the acquisition of Myrtle Recovery Centers, Inc. (“Myrtle”) effective on June 14, 2024, the Company offers behavioral health services, including substance abuse treatment. The acquisition of Myrtle is more fully discussed in Note 5.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Segments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manages and classifies its business into two reportable business segments: (i) Healthcare; and (ii) Labs and Life. Previously, Labs and Life were treated as separate segments, however, with the acquisition of Myrtle, the Company’s operational focus shifted such that it was appropriate to combine its Labs and Life segments and to operate Myrtle under the Company’s newly formed Healthcare segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Business Combination</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 24, 2022, Delwinds entered into a definitive Agreement and Plan of Merger, dated as of February 24, 2022, as amended on April 26, 2022, July 6, 2022 and August 12, 2022 (the “Merger Agreement”), with FOXO Technologies Inc., now known as FOXO Technologies Operating Company (“FOXO Technologies Operating Company”), DWIN Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Delwinds (“Merger Sub”), and DIAC Sponsor LLC (the “Sponsor”), in its capacity as the representative of the stockholders of Delwinds from and after the closing (the “Closing”) of the transactions contemplated by the FOXO Transaction Agreement (collectively, the “Transaction” or the “Business Combination”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination was approved by Delwinds’ stockholders on September 14, 2022, and closed on September 15, 2022 (the “Closing Date”) whereby Merger Sub merged into FOXO Technologies Operating Company, with FOXO Technologies Operating Company surviving the merger as a wholly owned subsidiary of the Company (the “Combined Company”), and with FOXO Technologies Operating Company security holders becoming security holders of the Combined Company. Immediately upon the Closing, the name of Delwinds was changed to FOXO Technologies Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the Closing, FOXO became a holding company whose wholly-owned subsidiary, FOXO Technologies Operating Company, conducted all of the core business operations. FOXO Technologies Operating Company maintains its two wholly-owned subsidiaries, FOXO Labs Inc. and FOXO Life, LLC. FOXO Labs maintains a wholly-owned subsidiary, Scientific Testing Partners, LLC, while FOXO Life Insurance Company was a wholly-owned subsidiary of FOXO Life, LLC. On February 3, 2023, the Company sold FOXO Life Insurance Company as more fully discussed in Note 13. On June 14, 2024, FOXO acquired Myrtle as more fully discussed in Note 5.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4633000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21398000	usd
CY2024Q2	FOXO	Working Capital Deficit WorkingCapitalDeficit	20817000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16167000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	551000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5300000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14900000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zsOOVoaBkEbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zZsqbpV11Rwc">RECLASSIFICATIONS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain items in the 2023 financial statements have been reclassified for comparison purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2024Q2	FOXO	Contractual Allowances ContractualAllowances	90000	usd
	FOXO	Contractual Allowances ContractualAllowances	90000	usd
CY2024Q2	FOXO	Contractual Allowance Related Adjustments ContractualAllowanceRelatedAdjustments	90000	usd
	FOXO	Contractual Allowance Related Adjustments ContractualAllowanceRelatedAdjustments	90000	usd
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	13334	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	398700	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2163000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11293000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3667000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18932000	usd
CY2024Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	310000	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2466000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	966000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2466000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2473000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13759000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4633000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21398000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5793128000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1287728000	shares
CY2023Q2	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	500000	usd
CY2023Q2	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	500000	usd
CY2023Q2	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	2369000	usd
CY2024Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	505000	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	500000	usd
	FOXO	Legal Costs LegalCosts	5000	usd
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	137000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	12000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	316000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	25000	usd
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-2394000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-11361000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-4441000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-19077000	usd
CY2024Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	310000	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2466000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	966000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2466000	usd
CY2024Q2	FOXO	Business Acquisition Pro Forma Net Income Loss Available To Common Stockholders Basic BusinessAcquisitionProFormaNetIncomeLossAvailableToCommonStockholdersBasic	-2704000	usd
CY2023Q2	FOXO	Business Acquisition Pro Forma Net Income Loss Available To Common Stockholders Basic BusinessAcquisitionProFormaNetIncomeLossAvailableToCommonStockholdersBasic	-13827000	usd
	FOXO	Business Acquisition Pro Forma Net Income Loss Available To Common Stockholders Basic BusinessAcquisitionProFormaNetIncomeLossAvailableToCommonStockholdersBasic	-5407000	usd
	FOXO	Business Acquisition Pro Forma Net Income Loss Available To Common Stockholders Basic BusinessAcquisitionProFormaNetIncomeLossAvailableToCommonStockholdersBasic	-21543000	usd
CY2024Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.24
CY2024Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.24
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-3.59
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-3.59
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.51
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.51
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-5.99
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-5.99
CY2024Q2	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageNumberOfSharesOutstandingBasic	11365	shares
CY2024Q2	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Diluted Shares Outstanding BusinessAcquisitionProFormaWeightedAverageNumberOfDilutedSharesOutstanding	11365	shares
CY2023Q2	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageNumberOfSharesOutstandingBasic	3851	shares
CY2023Q2	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Diluted Shares Outstanding BusinessAcquisitionProFormaWeightedAverageNumberOfDilutedSharesOutstanding	3851	shares
	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageNumberOfSharesOutstandingBasic	10653	shares
	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Diluted Shares Outstanding BusinessAcquisitionProFormaWeightedAverageNumberOfDilutedSharesOutstanding	10653	shares
	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageNumberOfSharesOutstandingBasic	3598	shares
	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Diluted Shares Outstanding BusinessAcquisitionProFormaWeightedAverageNumberOfDilutedSharesOutstanding	3598	shares
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1566000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1290000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	276000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	257000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	227000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	4000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	9000	usd
	us-gaap	Depreciation Depreciation	7000	usd
	us-gaap	Depreciation Depreciation	18000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	729000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	214000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2363000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	378000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	258000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	237000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	515000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1159000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2633000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2369000	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	7982000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	4203000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	7982000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4203000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1458000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1348000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1458000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P5Y10M24D
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.220	pure
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	15000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	15000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	421000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	433000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	446000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	460000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	473000	usd
CY2024Q2	FOXO	Lessee Operating Lease Liability Payments Due In Rolling Year Thereafter LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThereafter	464000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2697000	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	1239000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1458000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1348000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	FOXO	Shares Authorized SharesAuthorized	510000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q4	FOXO	Percentage Of Exercise Price PercentageOfExercisePrice	1.10	pure
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	25672	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	598877	shares
CY2024Q1	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2024-02-24
	FOXO	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Exerciable ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExerciable	4438813	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.23
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	25868	shares
CY2023Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	5002000	usd
CY2023Q1	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	200000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	251000	usd
CY2023Q2	FOXO	Merger Consideration And Buyers Third Party Expenses Transaction Gain MergerConsiderationAndBuyersThirdPartyExpensesTransactionGain	4751000	usd
CY2024Q2	us-gaap	Assets Assets	6906000	usd
CY2023Q4	us-gaap	Assets Assets	725000	usd
CY2024Q2	us-gaap	Revenues Revenues	28000	usd
CY2023Q2	us-gaap	Revenues Revenues	12000	usd
CY2024Q2	FOXO	Net Income Loss From Segments NetIncomeLossFromSegments	-570000	usd
CY2023Q2	FOXO	Net Income Loss From Segments NetIncomeLossFromSegments	-557000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2633000	usd
CY2023Q2	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease	-3521000	usd
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	542000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	492000	usd
CY2024Q2	us-gaap	Revenues Revenues	28000	usd
CY2023Q2	us-gaap	Revenues Revenues	12000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2163000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11293000	usd
CY2024Q2	FOXO	Amortization Of Consulting Fees AmortizationOfConsultingFees	144000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	52000	usd
CY2023Q2	FOXO	Amortization Of Consulting Fees AmortizationOfConsultingFees	1268000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	247000	usd
	us-gaap	Revenues Revenues	35000	usd
	us-gaap	Revenues Revenues	25000	usd
	FOXO	Net Income Loss From Segments NetIncomeLossFromSegments	-937000	usd
	FOXO	Net Income Loss From Segments NetIncomeLossFromSegments	-1494000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2633000	usd
	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease	-3521000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	843000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	717000	usd
	us-gaap	Revenues Revenues	35000	usd
	us-gaap	Revenues Revenues	25000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3667000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18932000	usd
	FOXO	Amortization Of Consulting Fees AmortizationOfConsultingFees	288000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	104000	usd
	FOXO	Amortization Of Consulting Fees AmortizationOfConsultingFees	3894000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1176000	usd
CY2024Q2	FOXO	Accrued Settlement AccruedSettlement	1974000	usd
CY2023Q4	FOXO	Accrued Settlement AccruedSettlement	2260000	usd
CY2022Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	6207000	usd
CY2023	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	300000	usd
CY2024Q2	us-gaap	Accelerated Share Repurchases Settlement Payment Or Receipt AcceleratedShareRepurchasesSettlementPaymentOrReceipt	50000	usd
	FOXO	Revenues Received Percentage RevenuesReceivedPercentage	0.15	pure
	us-gaap	Severance Costs1 SeveranceCosts1	1575000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	1575000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	462000	usd
	FOXO	Debenture Release DebentureRelease	2181000	usd
	FOXO	Payment In Kind Note Amendment PaymentInKindNoteAmendment	1339000	usd
	FOXO	Deemed Dividends From Exchange Offer DeemedDividendsFromExchangeOffer	2466000	usd
	FOXO	Deemed Dividends From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendsFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants	966000	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	340000	usd
	FOXO	Warrants Issuable For Finders Fees WarrantsIssuableForFindersFees	60000	usd
	FOXO	Stock Issued During Period Shares Shares Issuable For Acquisition StockIssuedDuringPeriodSharesSharesIssuableForAcquisition	235000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-032961-index-headers.html	Edgar Link	pending
0001493152-24-032961-index.html	Edgar Link	pending
0001493152-24-032961.txt	Edgar Link	pending
0001493152-24-032961-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
foxo-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
foxo-20240630_cal.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
foxo-20240630_def.xml	Edgar Link	unprocessable
foxo-20240630_pre.xml	Edgar Link	unprocessable
foxo-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

2024 Q3 Form 10-Q Financial Statement

#000149315224032961 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO FOXO TECHNOLOGIES INC. Stock $foxo

2024 Q3 Form 10-Q Financial Statement

#000149315224032961 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo